{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T00:53:13Z","timestamp":1794358393449,"version":"4.9.0"},"reference-count":84,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T00:00:00Z","timestamp":1742169600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T00:00:00Z","timestamp":1742169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"funder":[{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Human Vaccines &amp; Immunotherapeutics"],"published-print":{"date-parts":[[2025,12,31]]},"DOI":"10.1080\/21645515.2025.2474891","type":"journal-article","created":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T08:42:36Z","timestamp":1742200956000},"update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":10,"title":["A cost-effectiveness analysis of adult human papillomavirus vaccination strategies in Italy"],"prefix":"10.1080","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8654-2772","authenticated-orcid":false,"given":"Alhaji","family":"Cherif","sequence":"first","affiliation":[{"name":"Biostatistics and Research Decision Sciences, Health Economic and Decision Sciences (BARDS HEDS), Merck & Co., Inc","place":["Rahway, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9060-5999","authenticated-orcid":false,"given":"Cody","family":"Palmer","sequence":"additional","affiliation":[{"name":"Biostatistics and Research Decision Sciences, Health Economic and Decision Sciences (BARDS HEDS), Merck & Co., Inc","place":["Rahway, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Senese","sequence":"additional","affiliation":[{"name":"Value Access Vaccines, Infectious Diseases and Specialty, MSD Italy","place":["Rome, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6013-8779","authenticated-orcid":false,"given":"Angela","family":"Bechini","sequence":"additional","affiliation":[{"name":"University of Florence","place":["Florence, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Salvati","sequence":"additional","affiliation":[{"name":"University of Florence","place":["Florence, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2875-3744","authenticated-orcid":false,"given":"Paolo","family":"Bonanni","sequence":"additional","affiliation":[{"name":"University of Florence","place":["Florence, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9695-7549","authenticated-orcid":false,"given":"Sara","family":"Boccalini","sequence":"additional","affiliation":[{"name":"University of Florence","place":["Florence, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2025,3,17]]},"reference":[{"key":"e_1_3_6_2_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.30716"},{"key":"e_1_3_6_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2012.07.055"},{"key":"e_1_3_6_4_1","unstructured":"HPV Information Centre. Human papillomavirus and related diseases report - Italy. 2023. [accessed 2024 Feb 26]. https:\/\/hpvcentre.net\/statistics\/reports\/ITA.pdf."},{"key":"e_1_3_6_5_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.50.3870"},{"key":"e_1_3_6_6_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2019.37.15_suppl.e13108"},{"key":"e_1_3_6_7_1","first-page":"97","article-title":"Human papillomavirus vaccines: WHO position paper (2022 update)","volume":"50","author":"World Health Organization","year":"2022","unstructured":"World Health Organization. Human papillomavirus vaccines: WHO position paper (2022 update). Wkly Epidemiological Rec. 2022;50:97.","journal-title":"Wkly Epidemiological Rec"},{"key":"e_1_3_6_8_1","unstructured":"European Medicines Agency. Gardasil 9: human papillomavirus 9-valent vaccine (recombinant adsorbed). [accessed 2024 Jan 24]. https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/gardasil-9."},{"key":"e_1_3_6_9_1","unstructured":"European Medicines Agency. Cervarix: human papillomavirus vaccine [Types 16 18] (recombinant adjuvanted adsorbed). [accessed 2024 Jan 24]. https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/cervarix."},{"key":"e_1_3_6_10_1","unstructured":"European Medicines Agency. Gardasil: human papillomavirus vaccine [Types 6 11 16 18] (recombinant adsorbed). [accessed 2024 Jan 24]. https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/gardasil."},{"key":"e_1_3_6_11_1","unstructured":"Ministero della Salute. [Superior health council - session XLVI - Joint sections II and III - Sitting of 11 January 2007]. 2007 [accessed 2024 Feb 12]. https:\/\/www.salute.gov.it\/imgs\/C_17_pubblicazioni_600_allegato.pdf."},{"key":"e_1_3_6_12_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-015-1067-9"},{"key":"e_1_3_6_13_1","unstructured":"Giambi C. Stato di avanzamento della campagna vaccinale per l\u2019HPV: dati di copertura vaccinale al 31\/12\/2012\u2013Rapporto Semestrale. 2012 [accessed 2024 Feb 26]. https:\/\/www.epicentro.iss.it\/hpv\/pdf\/Aggiornamento_HPV_31122012.pdf."},{"key":"e_1_3_6_14_1","doi-asserted-by":"publisher","DOI":"10.1159\/000214924"},{"key":"e_1_3_6_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2012.06.091"},{"key":"e_1_3_6_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2015.08.010"},{"key":"e_1_3_6_17_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12962-017-0073-8"},{"key":"e_1_3_6_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2018.03.024"},{"key":"e_1_3_6_19_1","doi-asserted-by":"publisher","DOI":"10.1080\/13696998.2023.2282912"},{"key":"e_1_3_6_20_1","unstructured":"Ministero della Salute. Piano Nazionale Prevenzione Vaccinale 2017\u20132019. 2017 [accessed 2024 Feb 26]. https:\/\/www.salute.gov.it\/imgs\/C_17_pubblicazioni_2571_allegato.pdf."},{"key":"e_1_3_6_21_1","unstructured":"Ministero della Salute. Piano Nazionale Prevenzione Vaccinale 2023\u20132025. 2023 [accessed 2024 Feb 26]. https:\/\/www.trovanorme.salute.gov.it\/norme\/dettaglioAtto?id=95963&articolo=3."},{"key":"e_1_3_6_22_1","unstructured":"European Commission. Europe\u2019s beating cancer plan. 2021. https:\/\/health.ec.europa.eu\/system\/files\/2022-02\/eu_cancer-plan_en_0.pdf."},{"key":"e_1_3_6_23_1","doi-asserted-by":"publisher","DOI":"10.1136\/ijgc-2023-004275"},{"key":"e_1_3_6_24_1","doi-asserted-by":"publisher","DOI":"10.26355\/eurrev_202210_29922"},{"key":"e_1_3_6_25_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines10071133"},{"key":"e_1_3_6_26_1","doi-asserted-by":"publisher","DOI":"10.15167\/2421\u20134248\/jpmh2020.61.2.1626"},{"key":"e_1_3_6_27_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15051452"},{"key":"e_1_3_6_28_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10198\u2013021\u201301317\u2013w"},{"key":"e_1_3_6_29_1","unstructured":"Ministero della Salute. Coperture vaccinali al 31 dicembre 2022. 2022 [accessed 2024 May 2]. https:\/\/www.salute.gov.it\/imgs\/C_17_tavole_27_1_7_file.pdf."},{"key":"e_1_3_6_30_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2020.1744367"},{"key":"e_1_3_6_31_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0049699"},{"key":"e_1_3_6_32_1","doi-asserted-by":"publisher","DOI":"10.1371\/annotation\/39ddb7a9-3e7e-4544-a226-2e2b872a5116"},{"key":"e_1_3_6_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2014.11.002"},{"key":"e_1_3_6_34_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40261-017-0597-x"},{"key":"e_1_3_6_35_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10198-019-01044-3"},{"key":"e_1_3_6_36_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines12050504"},{"key":"e_1_3_6_37_1","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2022.1010237"},{"key":"e_1_3_6_38_1","doi-asserted-by":"publisher","DOI":"10.26355\/eurrev_202008_22648"},{"key":"e_1_3_6_39_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines11050924"},{"key":"e_1_3_6_40_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0091698"},{"key":"e_1_3_6_41_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2020.1852870"},{"key":"e_1_3_6_42_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.2008.01743.x"},{"key":"e_1_3_6_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2010.08.030"},{"key":"e_1_3_6_44_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11538-008-9338-x"},{"key":"e_1_3_6_45_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-020-05632-0"},{"key":"e_1_3_6_46_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines9080816"},{"key":"e_1_3_6_47_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-018-2954-7"},{"key":"e_1_3_6_48_1","unstructured":"European Commission. European cancer information system. [accessed 2023 Dec 12]. https:\/\/ecis.jrc.ec.europa.eu\/."},{"issue":"6","key":"e_1_3_6_49_1","first-page":"733","article-title":"Epidemiology and management of patients with ano-genital warts in Italy","volume":"66","author":"Suligoi B","year":"2010","unstructured":"Suligoi B, Salfa MC, Mariani L. Epidemiology and management of patients with ano-genital warts in Italy. Ig Sanita Pubbl. 2010;66(6):733\u2013756.","journal-title":"Ig Sanita Pubbl"},{"key":"e_1_3_6_50_1","doi-asserted-by":"publisher","DOI":"10.3201\/eid1301.060438"},{"key":"e_1_3_6_51_1","volume-title":"The yearbook of the united nations","author":"UN Department of Global Communications","year":"2019","unstructured":"UN Department of Global Communications. The yearbook of the united nations. New York: UN Dept. of Global Communications; 2019."},{"key":"e_1_3_6_52_1","volume-title":"2022 Revision of world population prospects","author":"United Nations Population Division","year":"2022","unstructured":"United Nations Population Division. 2022 Revision of world population prospects. New York: UN; 2022."},{"key":"e_1_3_6_53_1","unstructured":"Italian Institute of Statistics. I.Stat. [accessed 2024 Feb 26]. http:\/\/dati.istat.it\/?lang=en."},{"key":"e_1_3_6_54_1","doi-asserted-by":"publisher","DOI":"10.1186\/1478-7954-5-11"},{"key":"e_1_3_6_55_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-13-74"},{"key":"e_1_3_6_56_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0170091"},{"key":"e_1_3_6_57_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2458-12-623"},{"key":"e_1_3_6_58_1","unstructured":"Istituto Superiore di Sanit\u00e0. Screening Cervicale Dati Sorveglianza Passi. [accessed 2023 Dec 12]. https:\/\/www.epicentro.iss.it\/passi\/dati\/ScreeningCervicale."},{"key":"e_1_3_6_59_1","unstructured":"Programma Nazionale Esiti. Isterectomia: volume di ricoveri. 2023 [accessed 2024 Feb 26]. https:\/\/pne.agenas.it\/ospedaliera\/indicatori\/241?tab=italia&mode=0."},{"key":"e_1_3_6_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2015.12.007"},{"key":"e_1_3_6_61_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.28963"},{"key":"e_1_3_6_62_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2014.07.018"},{"key":"e_1_3_6_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(10)70230-8"},{"key":"e_1_3_6_64_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00405-017-4748-8"},{"key":"e_1_3_6_65_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2015.06.001"},{"key":"e_1_3_6_66_1","unstructured":"Ministero della Salute. Vaccinazione contro il papilloma virus (HPV) - Coperture vaccinali. [accessed 2024 Feb 16]. https:\/\/www.salute.gov.it\/portale\/documentazione\/p6_2_8_3_1.jsp?lingua=italiano&id=27."},{"key":"e_1_3_6_67_1","unstructured":"Agenzia Italiana del Farmaco. National report on medicines use in Italy. 2021. https:\/\/www.aifa.gov.it\/documents\/20142\/1740782\/Rapporto-OsMed-2021_EN.pdf."},{"key":"e_1_3_6_68_1","unstructured":"Struttura Interregionale Sanitari Convenzionati. AACCNN Medicina generale e successive aggiornamenti. [accessed 2024 Feb 26]. https:\/\/www.sisac.info\/default.do."},{"key":"e_1_3_6_69_1","unstructured":"Ministero della Salute. Tariffari nazionali delle prestazioni del Ssn. [accessed 2024 May 15]. https:\/\/www.salute.gov.it\/portale\/temi\/p2_6.jsp?id=3662&area=programmazioneSanitariaLea&menu=vuoto."},{"key":"e_1_3_6_70_1","doi-asserted-by":"publisher","DOI":"10.1007\/bf03320660"},{"key":"e_1_3_6_71_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2013.06.008"},{"key":"e_1_3_6_72_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-151-8-200910200-00007"},{"key":"e_1_3_6_73_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-016-2207-3"},{"key":"e_1_3_6_74_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jir281"},{"key":"e_1_3_6_75_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0075552"},{"key":"e_1_3_6_76_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pmedr.2022.101872"},{"key":"e_1_3_6_77_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw354"},{"key":"e_1_3_6_78_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0025-5564(97)00014-X"},{"key":"e_1_3_6_79_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1010971"},{"key":"e_1_3_6_80_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0909537"},{"key":"e_1_3_6_81_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1405044"},{"key":"e_1_3_6_82_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa061741"},{"key":"e_1_3_6_83_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)60777-6"},{"key":"e_1_3_6_84_1","first-page":"34110","article-title":"Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomised controlled trial","author":"Future I\/II Study Group","year":"2010","unstructured":"Future I\/II Study Group, Dillner J, Kjaer SK, Wheeler CM, Sigurdsson K, Iversen OE. Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomised controlled trial. BMJ. 2010; 34110.","journal-title":"BMJ"},{"key":"e_1_3_6_85_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2011.185"}],"container-title":["Human Vaccines &amp; Immunotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/21645515.2025.2474891","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/21645515.2025.2474891","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/21645515.2025.2474891","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:41:50Z","timestamp":1786034510000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/21645515.2025.2474891"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,17]]},"references-count":84,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12,31]]}},"alternative-id":["10.1080\/21645515.2025.2474891"],"URL":"https:\/\/doi.org\/10.1080\/21645515.2025.2474891","relation":{},"ISSN":["2164-5515","2164-554X"],"issn-type":[{"value":"2164-5515","type":"print"},{"value":"2164-554X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,17]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2024-07-29","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-02-12","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-02-28","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-03-17","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"2474891"}}